Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation

Blood

Volumn 106, Issue 5, 2005, Pages 1604-1611

  Del Conde, Ian ^a   Shrimpton, Corie N ^a   Thiagarajan, Perumal ^a   López, José A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7A; CD45 ANTIGEN; CHOLESTEROL; LIPOCORTIN 5; P SELECTIN GLYCOPROTEIN LIGAND 1; P SELECTIN GLYCOPROTEIN LIGAND 1 ANTIBODY; PADGEM PROTEIN; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; CELL SURFACE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPID RAFT; MACROPHAGE; MEMBRANE BINDING; MEMBRANE STRUCTURE; MEMBRANE VESICLE; MICROVESICLE; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; THROMBOCYTE ACTIVATION; THROMBOCYTE MEMBRANE;

EID: 23944509766     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-03-1095     Document Type: Article

References (45)

1. Bach RR. Initiation of coagulation by tissue factor. CRC Crit Rev Biochem. 1988;23:339-368.
2. Monroe DM, Roberts HR, Hoffman M. Platelet procoagulant complex assembly in a tissue factor-initiated system. Br J Haematol. 1994;88:364-371.
3. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134:1087-1097.
4. Koyama T, Nishida K, Ohdama S, et al. Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol. 1994;87:343-347.
5. Giesen PL, Rauch U, Bohrmann B, et al. Bloodborne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A. 1999;96:2311-2315.
6. Bogdanov VY, Balasubramanian V, Hathcock J, et al. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med. 2003;9:458-462.
7. Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med. 2003;197:1585-1598.
8. Hrachovinova I, Cambien B, Hafezi-Moghadam A, et al. Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med. 2003;9:1020-1025.
9. Palabrica T, Lobb R, Furie BC, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 1992;359:848-851.
10. Eppihimer MJ, Schaub RG. P-Selectin-dependent inhibition of thrombosis during venous stasis. Arterioscler Thromb Vasc Biol. 2000;20:2483-2488.
11. Kumar A, Villani MP, Patel UK, Keith JC Jr, Schaub RG. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. Circulation. 1999:99:1363-1369.
12. Nguyen DH, Hildreth JE. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol. 2000;74:3264-3272.
13. Scheiffele P, Rietveld A, Wilk T, Simons K. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J Biol Chem. 1999;274:2038-2044.
14. Shrimpton CN, Borthakur G, Larrucea S, et al. Localization of the adhesion receptor glycoprotein Ib-IX-V complex to lipid rafts is required for platelet adhesion and activation. J Exp Med. 2002;196:1057-1066.
15. Peyron P, Maridonneau-Parini I, Stegmann T. Fusion of human neutrophil phagosomes with lysosomes in vitro: involvement of tyrosine kinases of the Src family and inhibition by mycobacteria. J Biol Chem. 2001;276:35512-35517.
16. Morris SJ, Sarkar DP, White JM, Blumenthal R. Kinetics of pH-dependent fusion between 3T3 fibroblasts expressing influenza hemagglutinin and red blood cells: measurement by dequenching of fluorescence. J Biol Chem. 1989;264:3972-3978.
17. Sevinsky JR, Rao LV, Ruf W. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol. 1996;133:293-304.
18. Handa K, Jacobs F, Longenecker BM, Hakomori SI. Association of MUC-1 and PSGL-1 with low-density microdomain in T-lymphocytes: a preliminary note. Biochem Biophys Res Commun. 2001;285:788-794.
19. Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1:31-39.
20. Giurisato E, McIntosh DP, Tassi M, Gamberucci A, Benedetti A. T cell receptor can be recruited to a subset of plasma membrane rafts, independently of cell signaling and attendantly to raft clustering. J Biol Chem. 2003;278:6771-6778.
21. Li N, Mak A, Richards DP, et al. Monocyte lipid rafts contain proteins implicated in vesicular trafficking and phagosome formation. Proteomics. 2003;3:536-548.
22. Triantafilou M, Triantafilou K. Receptor cluster formation during activation by bacterial products. J Endotoxin Res. 2003;9:331-335.
23. Rauch U, Bonderman D, Bohrmann B, et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood. 2000;96:170-175.
24. Satta N, Toti F, Feugeas O, et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol. 1994;153:3245-3255.
25. Thiagarajan P, Tait JF. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem. 1991;266:24302-24307.
26. Kinnunen PK, Holopainen JM. Mechanisms of initiation of membrane fusion: role of lipids. Biosci Rep. 2000;20:465-482.
27. Burger KN. Greasing membrane fusion and fission machineries. Traffic. 2000;1:605-613.
28. Cullis PR, Fenske DB, Hope MJ. Physical properties and functional roles of lipids in membranes. In: Vance D, Vance J, eds. Biochemistry of Lipids, Lipoproteins and Membranes. Elsevier, New York, NY; 1996:1-33.
29. Thiagarajan P, Tait JF. Binding of annexin V/placental anticoagulant protein I to platelets: evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem. 1990;265:17420-17423.
30. Rauch U, Osende JI, Chesebro JH, et al. Stalins and cardiovascular diseases: the multiple effects of lipid-lowering therapy by statins. Atherosclerosis. 2000;153:181-189.
31. Liao Z, Cimakasky LM, Hampton R, Nguyen DH, Hildreth JE. Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. AIDS Res Hum Retroviruses. 2001;17:1009-1019.
32. Callahan MK, Popernack PM, Tsutsui S, et al. Phosphatidylserine on HIV envelope is a cofactor for infection of monocytic cells. J Immunol. 2003;170:4840-4845.
33. Zwaal RF. Membrane and lipid involvement in blood coagulation. Biochim Biophys Acta. 1978;515:163-205.
34. Brouckaert G, Kalai M, Krysko DV, et al. Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production. Mol Biol Cell. 2004;15:1089-1100.
35. van den Eijnde SM, van den Hoff MJ, Reutelingsperger CP, et al. Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J Cell Sci. 2001;114:3631-3642.
36. Arts EG, Kuiken J, Jager S, Hoekstra D. Fusion of artificial membranes with mammalian spermatozoa: specific involvement of the equatorial segment after acrosome reaction. Eur J Biochem. 1993;217:1001-1009.
37. Thiagarajan P, Benedict CR. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Circulation. 1997;96:2339-2347.
38. Simon DI, Chen Z, Xu H, et al. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med. 2000;192:193-204.
39. Phong MC, Gutwein P, Kadel S, et al. Molecular mechanisms of L-selectin-induced co-localization in rafts and shedding [corrected]. Biochem Biophys Res Commun. 2003;300:563-569.
40. Muller I, Klocke A, Alex M, et al. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. FASEB J. 2003;17:476-478.
41. Siddiqui FA, Desai H, Amirkhosravi A, Amaya M, Francis JL. The presence and release of tissue factor from human platelets. Platelets. 2002;13:247-253.
42. Frenette PS, Denis CV, Weiss L, et al. P-selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions in vivo. J Exp Med. 2000;191:1413-1422.
43. Mack M, Kleinschmidt A, Bruhi H, et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med. 2000;6:769-775.
44. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane: studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem. 1989;264:17049-17057.
45. Dietzen DJ, Page KL, Tetzloff TA. Lipid rafts are necessary for tonic inhibition of cellular tissue factor procoagulant activity. Blood. 2004;103:3038-3044.